Dr. Barbieri on SPOP Mutations in Prostate Cancer (OncLive)

Christopher E. Barbieri, MD, PhD, surgeon, researcher in prostate cancer genomics, Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, New-York Presbyterian, discusses the implications of SPOP mutations in patients with prostate cancer.